A hypochlorite-activated strategy for realizing fluorescence turn-on, type I and type II ROS-combined photodynamic tumor ablation.
Aggregation-induced emission
Hypochlorite
Photodynamic therapy
Photosensitizer
Turn-on fluorescence
Journal
Biomaterials
ISSN: 1878-5905
Titre abrégé: Biomaterials
Pays: Netherlands
ID NLM: 8100316
Informations de publication
Date de publication:
06 2023
06 2023
Historique:
received:
01
11
2022
revised:
28
03
2023
accepted:
01
04
2023
medline:
15
5
2023
pubmed:
11
4
2023
entrez:
10
4
2023
Statut:
ppublish
Résumé
The combination of cancer cell-activated fluorescence and the advantages of both type I and type II photodynamic therapy (PDT) capabilities to achieve a synergistic therapeutic effect in a complex tumor environment is highly desirable. Herein, we report an approach by means of tumor intracellular hypochlorite (ClO
Identifiants
pubmed: 37037180
pii: S0142-9612(23)00116-3
doi: 10.1016/j.biomaterials.2023.122108
pii:
doi:
Substances chimiques
Hypochlorous Acid
712K4CDC10
Photosensitizing Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
122108Commentaires et corrections
Type : ErratumIn
Informations de copyright
Copyright © 2023 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.